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 Abstract: A simple and efficient method was developed for the construction of the 
medicinally important 3-substituted-3-hydroxyoxindole and its 3-spirocyclic 
derivatives with readily available aniline derivatives as starting materials. This highly 
atom- and step-economical one-pot protocol was carried out under metal-free base- 
mediated conditions through a novel oxidative annulation strategy with oxygen as the 
oxidant. The key intermediates were isolated and confirmed. A reasonable reaction 
pathway was proposed and supported by both the preliminary experiments and 
computational studies.   
 
The 3-substituted-3-hydroxyoxindole and its synthetic derivatives have been well 
documented for various biological activities.1 This promising motif has been 
encountered in a large variety of natural products and pharmaceuticals. For example, 
convolutamydine A-E are a family of alkaloids containing a dibromohydroxyoxindole 
moiety, which were isolated from the Floridian marine bryozoans Amathia convolute 
and exhibited a potent activity in the differentiation of HL-60 cells.2 Maremycin A-D 
were isolated from a marine Streptomyces species, and some of them exhibited 
cytotoxicity to K562 human leukemia cell line etc.3 NSC635473 and YK-4-279 inhibit 
Ewing’s sarcoma family tumor cell growth and induce apoptosis.4 SM-130686 is a 
highly potent and orally active nonpeptidic growth hormone secretagogue.5 3-
Substituted-3-hydroxyoxindole’s synthetic derivatives such as the spirocyclic analogue 
have shown potential anti-cancer activity.6  
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 Figure 1. Representative examples of bioactive 3-substituted-3-hydroxyoxindole and 
its synthetic derivatives 
  The general class of 3-substituted-3-hydroxyoxindole possess appealing structure 
and a wide range of biological activities, and as such have been the focus of many 
methodological efforts.7 Previously reported methods for the synthesis of 3-
substituted-3-hydroxyoxindole 1 mainly employ the functionalized isatins, oxindoles 
or indoles as the starting materials through metal catalysis or organocatalysis (Scheme 
1, eq 1),8 for example, (i) the nucleophilic addition of isatins 2,9 (ii) the electrophilic 
addition of 3-hydroxyoxindoles 3,10 (iii) the hydroxylation of 3-substituted oxindoles 
3,11 (IV) oxidation of indoles.12 Despite these methods, examples for the construction 
of the 3-substituted-3-hydroxyoxindole or its 3-spirocyclic analogue with linear 
starting materials are limited, which include Kϋndig’s Pd-catalyzed asymmetric 
intramolecular α-arylation of amide enolates,13 Shibasaki’s Cu-catalyzed 
enantioselective intramolecular arylation of α-keto amides,14 Jia and Gao’s Ni-
catalyzed intramolecular nucleophilic addition of aryl chlorides to α-keto amides,15 
Xu’s novel synthesis of various 3-aryl-3-hydroxyoxindole derivatives via Rh-catalyzed 
asymmetric arylation-cyclization sequence with ortho-ketoester anilines as substrates 
16 and Du’s metal-free chiral aryliodine-mediated enantioselective synthesis of 3-
spirofurooxindoles via cascade oxidative C-O and C-C bond formation.17 Though these 
methods are generally efficient for the synthesis of 3-substituted-3-hydroxyoxindole, 
our interest in atom- and step-economical cascade reactions18 led us to investigate 
whether we could achieve the rapid synthesis of both 3-substituted-3-hydroxyoxindole 
and its 3-spirocyclic derivative 7 via metal-free oxidative annulation/ring distortion 
sequence with readily available aniline derivatives 6 as starting materials (Scheme 1, 
eq 2).  
 Scheme 1. Synthetic strategies for the 3-substituted-3-hydroxyoxindole and its derivatives  
 
  We initiated the study of this reaction with readily available aniline derivative 6a as 
the starting material (Table 1). Firstly, with CuI as catalyst and K3PO4 as base a screening 
of organic solvents was conducted. We found there is no desired product with THF as 
solvent (Table 1, entry 1). The reaction afforded the desired product in 24% yield with 
1,4-dioxane as solvent (Table 1, entry 2). By screening the other solvents the yield was 
only improved to 43% with DMF as solvent (Table 1, entries 3-6). It was found the 
reaction was effective as well in the absence of copper catalyst (Table 1, entry 7). We 
then conducted a base screening. Unfortunately there is no any improvement by 
switching to the other bases (Table 1, entries 8-11). Gratifyingly the yield was boosted 
to 84% by adding 0.2 equiv DABCO (Table 1, entry 12). By reducing the amount of 
K3PO4 the yield was decreased to 73% (Table 1, entry 13). The reaction can be carried 
out at lower temperature. However, the yield was decreased to 75% at 120 oC and 64% 
at 60 oC (Table 1, entries 14-15). Pleasingly, this reaction was equally effective on gram 
scale; 1.03 g of product 1a was easily prepared in 81% yield on 5 mmol scale (entry 
16).   
 
Table 1. Optimization of Reaction Conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a0.2 mmol 6a, 2.0 equiv base, 0.2 equiv DABCO, O2 atmosphere, 1.0 mL solvent, 150 oC, 4-24 h. 
bAnhydrous solvent. cIsolated yields. d 1.0 equiv K3PO4. e120 oC. f60 oC. g 5 mmol Scale, 1.03 g 1a 
was prepared. 
  With the optimum conditions in hand, we then prepared various aniline derivatives 
6 according to the known procedure and subjected to the reaction conditions (Table 
2).19 First, we examined the substrates with an alkyl substituent α to the carbonyl 
group. The substrates are effective with either alkyl or benzyl substituent on the 
nitrogen (1a-c), although the reactions require higher temperature and longer reaction 
time. The substrates with a phenyl substituent α to the carbonyl group were then 
investigated. For the substrates with a methyl group on the nitrogen, all the reactions 
gave the desired products in good yields at 120 oC in 4 h (1d-h). The substrates with a 
phenyl group on the nitrogen are effective as well (1i-k). Both electron withdrawing 
and donating groups are tolerated under the optimized reaction conditions. Halogen 
such as chlorine and fluorine are compatible with the reaction conditions (1g-h and 
1k), which could be used for the functional handles for further transformations.     
entrya cat. (0.2 
equiv) 
base (2.0 
equiv)  
additive 
(0.2 equiv) 
solventb yields 
 (%)c 
1 CuI K3PO4 ̶ THF 0 
2 CuI K3PO4 ̶ 1,4-dioxane 24 
3 CuI K3PO4 ̶ toluene 20 
4 CuI K3PO4 ̶ CH3CN 18 
5 CuI K3PO4 ̶ DMA 36 
 6 CuI K3PO4 ̶ DMF 43  
7 ̶ K3PO4 ̶ DMF 40 
8 ̶ NaOH ̶ DMF 18 
9 ̶ Cs2CO3 ̶ DMF 39 
10 ̶ KOH ̶ DMF trace 
11 ̶ Cs2CO3  DMF 36 
12 ̶ K3PO4 DABCO DMF 84 
13 d ̶ K3PO4 DABCO DMF 73 
14e ̶ K3PO4 DABCO DMF 75 
15f ̶ K3PO4 DABCO DMF 64 
 16g ̶ K3PO4 DABCO DMF 81 
 
Table 2. Substrate scopes for the synthesis of 3-hydroxyoxindoles 
 
 
Next, we prepared various aniline derivatives with benzoic acid ring α to the carbonyl 
group according to the known procedure and subjected to the reaction conditions 
(Table 3).20 Interestingly, these substrates could undergo further lactamization to give 
the tetracyclic 3-spriooxindole benzofuranones successfully. Most of the substrates 
could undergo the oxidative cyclization successfully even in the absence of DABCO 
(such as 7c and 7d etc). However, some of the substrates do need stoichiometric 
amount of DABCO to deliver the corresponding products in moderate yields (such as 
7c and 7d etc). Generally the substrates with either electron donating or electron 
withdrawing groups are effective and gave the corresponding products in good yields 
under the optimum conditions (7b-g). Halogens such as F, Cl and Br are tolerated under 
the reaction conditions (7e-f, 7j-l), which could be used as functional handle for the 
further transformations. The structure of 7l was further    
Table 3. Substrate scopes for the synthesis of 3-spriooxindole benzofuranones 
 
confirmed by X-ray analysis.21 Finally, we tested the substrates with substituent on 
both aromatic rings, which also gave the desired products in good yields under the 
optimum conditions (7m-o).  
During the annulation reactions small amounts of 2-hydroxy-1-methyl-2-
phenylindolin-3-one 9d or spiro[indoline-2,1’-isobenzofuran]-3,3’-diones 10m were 
detected  except the remaining starting material and the desired product. To 
demonstrate whether compounds 9d and 10m are the intermediates of this 
annulation reaction, we managed to isolate these two compounds and treated them 
under the reaction conditions respectively (Scheme 2). As we expected, both 
compounds 9d and 10m could be converted into the desired 3-phenyl-3-hydroxy 
oxindole 1d and 3-spirooxindole benzofuranone product 7m in good yields 
respectively.  
 
 
 
 Scheme 2. Reaction intermediates confirmation 
 
Scheme 3. Proposed reaction pathway 
 
Based on the above experiment results and previous reports from the other groups,20, 
22 a plausible reaction pathway for this annulation is depicted in Scheme 3. In the 
presence of base the aniline derivative 1 could be oxidized to give the diketone IV via 
intermediates I-III under the aerobic oxidation condition in a pathway reported by 
Wang and Zhang.23 The diketone IV was then cyclized to give the 2-substituted-2-
hydroxy-3-indolinone V. Followed by a 1,2-migration or ring distortion the 3-
substituted-3-hydroxy-2-oxindole or its 3-spirocyclic derivative 7 could be obtained in 
a similar pathway as described by Kafka and co-workers.22 
 
In order to understand the energetics of this rearrangement from V to VI, we 
performed density functional theory (DFT) calculations using Gaussian09 program. 24 
All stationary point structures were optimized using B3LYP25 functional and 6-31+G(d) 
basis set with a conductor like polarizable continuum model (CPCM)26 solvation model 
in DMF in Gaussian09. Both local minima and transition structures are confirmed by 
vibrational frequencies with 0 and 1 imaginary frequency, respectively. All transition 
structures are checked by intrinsic reaction coordinate (IRC) calculation. Hence, the 
barrier for this base-catalyzed α-ketol rearrangement from V to VI was found to be 
very low, i.e. 16.0-18.7 kcal mol-1 for the examples we calculated, which is for 1a, 1b, 
1c, 1f and 1k (see Table 2 and Scheme 3). This process was found to be in favor of the 
deprotonated form of 3-substituted-3-hydroxyoxindole VI by 6-7.5 kcal mol-1 (see 
Greact in Scheme 3), making the reverse process a barrier of 22.1-24.1 kcal mol-1. 
Moreover, their protonated structures 2-substituted-2-hydroxyoxindole VII and 3-
substituted-3hydroxyoxindole 1 were also studied, with 1 being found to be more 
thermodynamically stable than VII by ca 10 kcal mol-1 (see G’react in Scheme 3). Similar 
result was also found when comparing the free energy of 10 and 7 (Scheme 2) and 
their analogues, in which 7 has lower free energy by ca 11 kcal mol-1 (see SI for more 
information). Overall, calculations suggested that the thermodynamic stability of the 
lactam VI or 1 was the driven force for this rearrangement.     
Scheme 3. Computational studies of base-mediated α-ketol rearrangement reaction. 
CPCM(DMF)-B3LYP/6-31+G(d) free energies are quoted in kcal mol−1 and selected distances are 
shown in Å. Computed structures are displayed with CYLview.27 
 
  In summary, we have developed a novel and efficient method for the synthesis of 
both 3-substituted-3-hydroxyoxindole and its 3-spirocyclic derivative with readily 
available linear aniline derivatives as starting materials. This highly atom- and step-
economical one-pot protocol was carried out under metal-free base-mediated 
conditions through a novel oxidative annulation strategy with oxygen as the oxidant. 
One quaternary carbon center, more than one new cycle and three new bonds were 
formed in only one synthetic step to give the privileged heterocyclic systems with high 
selectivity and atom economy. 
       
 ACKNOWLEDGMENT  
We thank the National Science Foundation of China (21502101) and Natural Science 
Foundation for Distinguished Young Scholars of Zhejiang Province (LR15H300001), 
Thousand-Talent Program of Zhejiang Province and Zhejiang University of Technology 
for financial support. We acknowledge Mr Zhangkai Dong for the preparation of some 
substrates, and the University of Nottingham for the use of High Performance 
Computing Facility.  
 
Notes and References 
1. (a) P. Satyamaheshwar, Curr. Bioact. Compd., 2009, 5, 20; (b) K. Shen, X. Liu, L. Lin, X. Feng, Chem. 
Sci., 2012, 3, 327; (c) B. Yu, Z. Yu, P.-P. Qi, D.-Q. Yu, H.-M. Liu, Eur. J. Med. Chem., 2015, 95, 35; (d) 
B. Yu, Y.-C. Zheng, X.-J. Shi, P.-P. Qi, H.-M. Liu, Anti-cancer agents in med. Chem., 2016, 16, 1315. 
2. (a) Y. Kamano, H.-P. Zhang, Y. Ichihara, H. Kizu, K. Komiyama and G. R. Pettit, Tetrahedron Lett., 
1995, 36, 2783; (b) H.-P. Zhang, Y. Kamano, Y. Ichihara, H. Kizu, K. Komiyama, H. Itokawa and G. R. 
Pettit, Tetrahedron, 1995, 51,5523. 
3. Y.-Q. Tang, I. Sattler, R. Thiericke, S. Grabley and X.-Z. Feng, Eur. J. Org. Chem., 2001, 261. 
4. S. Rahim, E. M. Beauchamp, Y. Kong, M. L. Brown, J. A. Toretsky, A. Üren, PLoS ONE, 2001, 6, 
e19343. 
5. (a) T. Tokunaga, W. E. Hume, T. Umezome, K. Okazaki, Y. Ueki, K. Kumagai, S. Hourai, J. 
Nagamine, H. Seki, M. Taiji, H. Noguchi, R. Nagata, J. Med. Chem., 2011, 44, 4641; (b) T. Tokunaga, 
W. E. Hume, J. Nagamine, T. Kawamura, M. Taiji, R. Nagata, Bioorg. Med. Chem. Lett., 2005, 15, 
1789. 
6. (a) P. Hewawasam, V. K. Gribkoff, Y. Pendri, S. I. Dworetzky, N. A. Meanwell, E. Martinez, C. G. 
Boissard, D. J. Post-Munson, J. T. Trojnacki, K. Yeleswaram, L. M. Pajor, J. Knipe, Q. Gao, R. Perrone 
and J. E. Starrett, Jr. Bioorg. Med. Chem. Lett., 2002, 12, 1023; (b) S. Rana, E. C. Blowers, C. Tebbe, 
J. I. Contreras, P. Radhakrishnan, S. Kizhake, T. Zhou, R. N. Rajule, J. L. Arnst, A. R. Munkarah, R. 
Rattan and A. Natarajan, J. Med. Chem., 2016, 59, 5121. 
7.  (a) F. Zhou, Y.-L. Liu, J. Zhou, Adv. Synth. Catal., 2010, 352, 1381; (b) K. Shen, X. Liu, L. Lin, X. 
Feng, Chem. Sci., 2012, 3, 327; (c) G. S. Singh, Z. Y. Desta, Chem. Rev., 2012, 112, 6104; (d) N. R. 
Ball-Jones, J. J. Badillo, A. K. Franz, Org. Bio. Chem., 2012, 10, 5165; (e)R. Dalpozzo, G. Bartoli, G. 
Bencivenni, Chem. Soc. Rev., 2012, 41, 7247; (f) R. Rios, Chem. Soc. Rev., 2012, 41, 1060. 
8. (a) A. Kumar and S. S. Chimni, RSC. Adv., 2012, 2, 9748; (b) Y. Liu, F. Zhu, C. Wang, J. Zhou, Chin. 
J. Org. Chem., 2013, 33, 1595 and references therein. 
9. (a) M. Montesinos-Magraner, C. Vila, G. Blay, I. Fernandez, M. C. Munoz, J. R. Pedro, Org. Lett., 
2017, 19, 1546; (b) X. Bai, G. Zeng, T. Shao and Z. Jiang, Angew. Chem., Int. Ed., 2017, 56, 3684; (c) 
B.-S. Li, Y. Wang, R. S. J. Proctor, Y. Zhang, R. D. Webster, S. Yang, B. Song, Y. R. Chi, Nat. Commun., 
2016, 7, 12933; (d) J. Xu, S. Yuan, M. Miao, Z. Chen, J. Org. Chem., 2016, 81, 11454; (e) Y. Zhang, 
B.-W. Wei, H. Lin, L. Zhang, J.-X. Liu, H.-Q. Luo, X.-L. Fan, Greem. Chem., 2015, 17, 3266. 
10. T. Luong, S. Chen, K. Qu, E. L. McInturff, M. J. Krische, Org. Lett., 2017, 19, 966. 
11. (a) W. Guo, Y. Liu, C. Li, Org. Lett., 2017, 19, 1044; (b) H. F. T. Klare, A. F. G. Goldberg, D. C. 
Duquette, B. M. Stoltz, Org. Lett., 2017, 19, 988. 
12. (a) S. Tadano, Y. Sugimachi, M. Sumimoto, S. Tsukamoto, H. Ishikawa, Chem. Eur. J., 2016, 22, 
1277; (b) L. Wang, X. Qu, L. Fang, Z. Li, S. Hu, F. Wang, Eur. J. Org. Chem., 2016, 5494. 
13. Y.-X. Jia, J. M. Hillgren, E. L. Watson, S. P. Marsden, E. P. Kϋndig, Chem. Commun., 2008, 4040. 
14. (a) D. Tomita, K. Yamatsugu, M. Kanai, M. Shibasaki, J. Am. Chem. Soc., 2009, 131, 6946; (b) L. 
Yin, M. Kanai, M. Shibasaki, Angew. Chem., Int. Ed., 2011, 50, 7620. 
15. J.-X. Hu, H. Wu, C.-Y. Li, W.-J. Sheng, Y.-X. Jia, J.-R. Gao, Chem. Eur. J., 2011, 17, 5234. 
16. Y. Li, D.-X. Zhu, M.-H. Xu, Chem. Commun., 2013, 49, 11659. 
17. (a) Y. Cao, X. Zhang, G. Lin, D. Zhang-Negrerie, Y. Du, Org. Lett., 2016, 18, 5580; (b) B. Zhang, X. 
Zhang, B. Hu, D. Sun, S. Wang, D. Zhang-Negrerie, Y. Du, Org. Lett., 2017, 19, 902. 
18. (a) F. Zhang, M. F.Greaney, Angew. Chem., Int. Ed. 2010, 49, 2768; (b) F. Zhang, S. Das, A. J. 
Walkinshaw, A. Casitas, M. Taylor, M. G. Suero, M. J. Gaunt, J. Am. Chem. Soc. 2014, 136, 8851; 
(c) H. Xie, M. Ding, M. Liu, T. Hu, F. Zhang, Org. Lett., 2017, 19, 2600. 
19. (a) K. Okuma, S. Ozaki, J.-i. Seto, N. Nagahora, K. Shioji, Heterocycles, 2010, 81, 935; (b) Y. Zhu, 
M. M. Alam, S. A. Jenekhe, Macromolecules, 2003, 36, 8958. 
20. R. M. Letcher, N.-C. Kwok, W.-H. Lo, K.-W. Ng, J. Chem. Soc., Perkin Trans. 1, 1998, 1715.  
21. S. Kafka, A. Klásek, J. Košmrlj, J. Org. Chem., 2001, 66, 6394. 
22. CCDC: 1539598. 
23. (a) J.-W. Yu, S. Mao, Y.-Q. Wang, Tetrahedron. Lett., 2015, 56, 1575; (b) X. Wang, R.-X. Chen, 
Z.-F. Wei, C.-Y. Zhang, H.-Y. Tu, A.-D. Zhang, J. Org. Chem., 2016, 81, 238.  
24. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. 
Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, 
A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. 
Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. 
E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, 
J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. 
M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. 
Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, 
V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. 
B. Foresman, J. V. Ortiz, J. Cioslowski, D. J. Fox, Gaussian 09, Revision E.01, Gaussian, Inc., 
Wallingford CT, 2009. 
25. (a) C. Lee, W. Yang, R. G. Parr, Phys. Rev. B 1988, 37, 785; (b) A. D. Becke, J. Chem. Phys. 1993, 
98, 5648; (c) R. G. Parr, Annu. Rev. Phys. Chem. 1995, 46, 701. 
26. M. Cossi, N. Rega, G. Scalmani, V. Barone, J. Comput. Chem. 2003, 24, 669. 
27. CYLview, 1.0b; Legault, C. Y., Université de Sherbrooke, 2009 (http://www.cylview.org). 
 
 
 
 
 
 
 
 
 
 
Metal-Free Base-Mediated Oxidative Annulation Cascades to 3-
Substituted-3-Hydroxyoxindole and its 3-Spirocyclic Derivative 
Min Liu,Ɨ Chunxia Zhang,Ɨ Mingruo Ding, Bencan Tang* and Fengzhi Zhang* 
 
 
